The company specializes in the production and export of H-Acid, a chemical intermediate used primarily in the textile and leather industries to create various dyes. It operates a manufacturing facility in Maharashtra and sells its products to industrial clients both in India and internationally.
The company operates in a highly cyclical and fragmented commodity chemical market with no evidence of pricing power, as seen in the volatile net margins and low average ROCE. While they claim a leading position in H-Acid, the lack of differentiated technology or high switching costs means they are price-takers subject to global supply swings, particularly from China.
Capital has been directed toward solar power plants for captive consumption to reduce costs and the incorporation of new subsidiaries for expansion. However, the historical returns on these investments are poor, with an average ROE of -4.1%, suggesting that reinvested cash has not yet generated meaningful shareholder value.
Five years out, the investment collapsed as the company remained trapped in a commodity death spiral. Despite pouring capital into solar plants and new subsidiaries, the business failed to overcome its status as a price-taker against Chinese industrial scale. The promoter-led capital allocation proved to be a value-destructive treadmill; while revenue grew, the lack of pricing power meant that every uptick in raw material costs or dip in H-Acid prices resulted in net losses. Eventually, the combination of persistent negative returns on equity and the dilution from promoter-issued warrants exhausted the remaining minority shareholder patience, leaving the company as a stagnant, low-utility asset with no path to profitability.
RichFakir rates Shree Hari Chemicals Export Ltd's business quality as poor — 19/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
RichFakir's educational verdict on Shree Hari Chemicals Export Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
View the full live analysis →